Stay updated with breaking news from Greg Gin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, and welcome to the Abeona Therapeutics Second Quarter 2023 Update Conference Call [Operator Instructions]. As a reminder, today's conference is being recorded.
On track for Biologics License Application (BLA) submission in third quarter of 2023
Expects to submit BLA for EB-101 to FDA in late-2Q/early-3Q 2023 based on positive Phase 3 VIITAL™ study results announced in 4Q 2022 Advancing AAV-based gene therapy... | March 29, 2023
There is breaking news that will come as a relief to many parents of young children. pfizer late today said it is requesting emergency use authorization for the two-shot reg gin of its vaccine in children as young as 6 months old. a version is already approved for kids 5 to 11. it's got a lower dose than the 12 and older shot. this newest one would be lower still. federal authorities hope to get it approved by late this month. i want to talk with former cdc director dr. tom frieden who just published a piece entitled why i'm cautious about covid vaccine. ages 6 months to five years. if they ge...
Abeona Therapeutics Achieves Target Enrollment in Pivotal Phase 3 VIITAL™ Study of EB-101 in RDEBTopline data from VIITAL™ expected in the third quarter of 2022 - read this article along with other careers information, tips and advice on BioSpace